Blossom Genetics
About Shark Attack
SAIndica HybridThese buds tend to be very dark in colour and quite dense, emitting a fragrance that lures you in just like a predator of the sea. Pine, hash, lemon, and floral notes blend seamlessly for a flavour that’s hard to say no to.
Dutch Bred
Shark Attack, an indica-dominant strain by Dinafem Seeds. When your parents are Super Skunk and White Widow, you have some big shoes to fill. Luckily, Shark Attack is a winner.
One of the many things that makes this strain unique is her mellow THC content that maxes out around 16% along with roughly 10% CBD. These buds tend to be very dark in colour and quite dense, emitting a fragrance that lures you in just like a predator of the sea. Pine, hash, lemon, and floral notes blend seamlessly for a flavour that’s hard to say no to.
Shark Attack has become a pretty popular strain for home growers as she is easy to care for and produces a large yield. Plants can reach some rather tall heights, but in general, are more compact than other branchy relatives. Suitable for indoor or outdoor cultivation, this strain takes about 7 to 8 weeks to fully mature and is widely available in feminized seed form.
Description provided by Wikileaf.
Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About Hilltop Leaf Holdings Ltd
We believe in creating a science-led Scottish pharmaceutical product while bringing jobs and innovation to the South of Scotland.
Hilltop Leaf is a private medicinal cannabis cultivation and extraction business for cannabis based products for medicinal use in humans (CBPMs)
GMP accredited facility focused on creating a science-led Scottish pharmaceutical product while bringing jobs and innovation to the South of Scotland. The company aims to play a leading role in the provision of full spectrum cannabinoid oils, APIs and cannabis based medicinal products.
The beauty of cannabis is that all it is doing is supplementing the body’s natural cannabis system called the endocannabinoid system. Humans, as well as many other animals, have this natural system throughout the body.
The system, in the brain for example, has an effect on memory, control of movement, modulation of pain, development of nerve growth and plasticity, and the adaptability of the nervous system. It has an influence on sleep, appetite, anxiety and social behaviour to name but a few important functions. Outside the brain the endocannabinoid system is also widespread and has effects on the bladder, the bowels, the reproductive system, the heart, the hormonal and metabolic systems and has a role in the control of cancer. In other words, it is one of the most important bodily systems – yet one of the least understood.
We know that there are at least two cannabinoid receptors in the body, CB1 and CB2, but in the next few years we are certain that more receptors will be isolated. There are natural chemicals circulating in the body that attach to these receptors and it is through this chemical attachment that the endocannabinoid system performs its functions. The natural plant cannabinoids are supplementing and assisting the body’s natural circulation of cannabis-like chemicals. Thus, it is not surprising that the plant has many medical benefits.
Cultivate
The plants will be grown in a high security facility with climate controlled conditions. Cultivation to GAcP standards with EU GMP drying and processing.
Extract
The extraction facility will be constructed alongside the cultivation within the same high security building. Extraction and Processing facility to EU GMP standards.
End Product
We intend to produce a cannabis based medicinal product (CBMP) suitable for specialist prescription to UK patients via our clinical and distribution partners.
hilltopleaf.com/
Further National Health-Service Information on